Innovative Research — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Innovative Research is a long-established, private biotech supplier providing critical biological materials and services to the global research community. Its core business revolves around a vast catalog of biomaterials—including human plasma, animal sera, and antibodies—complemented by custom manufacturing, ELISA/CLIA kits, and CRO services. The company differentiates itself through a strong focus on quality, customization, and customer support, serving academic, government, and industrial labs for over two decades. It operates as a revenue-generating services and products company without a proprietary therapeutic pipeline.

Antibodies

Technology Platform

Integrated supply chain and service infrastructure for biological materials, including a biorepository, custom manufacturing, and immunoassay (ELISA/CLIA) kit development.

Opportunities

Growing demand for high-quality, reproducible research materials and increased outsourcing of lab services by academic and biopharma researchers present significant opportunities.

The trend towards personalized and niche research drives need for custom biologicals, a core strength of the company.

Risk Factors

Key risks include intense competition from large global reagent suppliers, potential disruptions in the supply chain for human and animal biological materials, and reputational damage from any lapse in product quality or consistency.

Competitive Landscape

Operates in the highly competitive life science tools and reagents market, competing against giants like Thermo Fisher and Merck as well as numerous niche suppliers. Differentiates through a strong focus on customization, personalized service, and quality control for both off-the-shelf and made-to-order products.

More companies in Biologics / Biosimilars →More companies in United States →